Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study
暂无分享,去创建一个
Jeffrey A. Cohen | D. Arnold | D. Snydman | H. Weiner | H. Hartung | E. Havrdová | K. Selmaj | A. Coles | D. Margolin | D. Compston | N. Daizadeh | D. Compston | M. Chirieac | S. Wray | Jeffrey A. Cohen | Douglas L Arnold | Krzysztof W Selmaj | J. A. Cohen | D. R. Snydman | Howard L. Weiner | Madalina C. Chirieac